State Street’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

State Street’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-235,863	Closed	-$2.4M	–	4576
2023 Q3	$2.4M	Buy	235,863 +75,411	+47%	+$574K	﹤0.01%	3252
2023 Q2	$754K	Buy	160,452 +41,268	+35%	+$190K	﹤0.01%	3618
2023 Q1	$551K	Buy	119,184 +1,200	+1%	+$5.28K	﹤0.01%	3710
2022 Q4	$428K	Buy	117,984 +9,745	+9%	+$43.2K	﹤0.01%	3825
2022 Q3	$512K	Buy	108,239 +2,659	+3%	+$13.4K	﹤0.01%	3768
2022 Q2	$511K	Buy	105,580 +14,782	+16%	+$89.9K	﹤0.01%	3822
2022 Q1	$577K	Buy	90,798 +53,491	+143%	+$288K	﹤0.01%	3984
2021 Q4	$232K	Buy	+37,307	New	+$292K	﹤0.01%	4281

State Street's THRN Position: Q4 2023 in Review

State Street sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 235,863 shares — an estimated $2.4M sold.

State Street first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $2.4M in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

State Street reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
State Street sold 235,863 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $2.4M.
State Street first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
State Street's Thorne Healthtech, Inc. Common Stock position peaked at $2.4M in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.